Global Oral Clinical Nutrition Supplement Market Overview
Oral Clinical Nutrition Supplement Market Size was estimated at 62.34 (USD Billion) in 2022.The Oral Clinical Nutrition Supplement Market Industry is expected to grow from 67.1(USD Billion) in 2023 to 130.0 (USD Billion) by 2032. The Oral Clinical Nutrition Supplement Market CAGR (growth rate) is expected to be around 7.63% during the forecast period (2024 - 2032).
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Key Oral Clinical Nutrition Supplement Market Trends Highlighted
According to market analysis, the primary market drivers for oral clinical nutrition supplements encompass the increasing incidence of chronic ailments, the growing geriatric population and the growing interest in individualized nutrition. This is present in developing economies, novel formulations and delivery mechanisms, and supplements with assisted technology. Such changes include an increase in telehealth and e-commerce, plant-based ingredients, and gut-oriented approaches.
Oral Clinical Nutrition Supplement Market Drivers
Rising Prevalence of Chronic Diseases
The Oral Clinical Nutrition Supplement Market Industry is driven primarily by the growing burden of chronic ailments such as cancer, cardiovascular disorders and diabetes, among others. These diseases frequently lead to malnutrition, loss of appetite, and unintended weight loss, among others. Besides, oral clinical nutrition supplements contain calories and appropriate macro and micronutrients to augment the meals of the patients. It contains important elements that are often missed in patients' diets for chronic diseases.
Also, dietary supplements may assist in alleviating the signs and symptoms of the disease, enhancing the well-being of the patients, as well as decreasing complications when taken at the right exposure.
Growing Awareness of Nutritional Needs
There is an emerging knowledge among healthcare professionals and the public at large about the significance of nutrition in health maintenance today. This knowledge partly explains the increase in the demand for oral clinical nutrition supplements. They allow those individuals who are unable to consume a healthy diet in the long run due to some reasons and conditions to still get all the necessary nutrients. The fact that these days, people are more informed about nutrition and learn that supplements are indeed efficient cannot be neglected as one of the main factors that determine the growth of the market.
Technological Advancements
The developments and advancements in the field of nutrition by way of technology also account for the expansion of the Oral Clinical Nutrition Supplement Market Industry. The advancement in the research for new, efficient, and more palatable formulations for oral clinical nutrition has been developed. An example is the new enteral feeding tube that has made it easier and more convenient for patients to receive the right nutrition.
Oral Clinical Nutrition Supplement Market Segment Insights
Oral Clinical Nutrition Supplement Market Patient Type Insights
The Oral Clinical Nutrition Supplement Market is segmented by patient type into malnourished cancer patients, critically ill patients, trauma patients, and elderly patients. Among these segments, malnourished cancer patients are expected to hold the largest market share in 2023, owing to the high prevalence of malnutrition in cancer patients. Critically ill patients are also expected to account for a significant share of the market, as they often require specialized nutritional support to improve their clinical outcomes. Trauma patients and elderly patients are also important segments of the market, as they often have increased nutritional needs due to their conditions.The Oral Clinical Nutrition Supplement Market for malnourished cancer patients is expected to reach a value of USD 22.5 billion by 2032, growing at a CAGR of 8.2% during the forecast period. The increasing prevalence of cancer worldwide is a major factor driving the growth of this segment. According to the World Health Organization, there were an estimated 19.3 million new cases of cancer in 2020, and this number is expected to increase to 28.4 million by 2040. Malnutrition is a common problem among cancer patients, affecting up to 80% of patients.This is due to a number of factors, including the effects of cancer treatment, changes in appetite, and difficulty eating. Oral clinical nutrition supplements can help to improve the nutritional status of malnourished cancer patients and improve their overall health and well-being. The Oral Clinical Nutrition Supplement Market for critically ill patients is expected to reach a value of USD 18.7 billion by 2032, growing at a CAGR of 7.9% during the forecast period. The increasing number of critically ill patients worldwide is a major factor driving the growth of this segment.According to the World Health Organization, there were an estimated 46.4 million cases of critical illness in 2019, and this number is expected to increase to 64.8 million by 2030. Critically ill patients often require specialized nutritional support to improve their clinical outcomes. Oral clinical nutrition supplements can help to provide these patients with the nutrients they need to recover from their illness. The Oral Clinical Nutrition Supplement Market for trauma patients is expected to reach a value of USD 12.3 billion by 2032, growing at a CAGR of 7.5% during the forecast period.The increasing number of trauma cases worldwide is a major factor driving the growth of this segment. According to the World Health Organization, there were an estimated 1.35 million deaths from trauma in 2019, and this number is expected to increase to 1.7 million by 2030. Trauma patients often have increased nutritional needs due to their injuries. Oral clinical nutrition supplements can help to provide these patients with the nutrients they need to recover from their injuries. The Oral Clinical Nutrition Supplement Market for elderly patients is expected to reach a value of USD 15.6 billion by 2032, growing at a CAGR of 7.6% during the forecast period.The increasing number of elderly people worldwide is a major factor driving the growth of this segment. According to the United Nations, there were an estimated 962 million people aged 65 or older in 2019, and this number is expected to increase to 2.1 billion by 2050. Elderly patients often have increased nutritional needs due to their age. Oral clinical nutrition supplements can help to provide these patients with the nutrients they need to stay healthy and active.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Oral Clinical Nutrition Supplement Market Clinical Indication Insights
The Oral Clinical Nutrition Supplement Market is classified on the basis of clinical indication into Cancer-related malnutrition, Critical illness, Trauma, Sarcopenia, and Others. Among these, Cancer-related malnutrition is anticipated to acquire the largest market share throughout the forecast period. The high prevalence of cancer and the need for nutritional support in cancerous or malignant conditions is anticipated to drive the growth of the segment. According to 2020 GLOBOCAN estimates about World cancer statistics, there were approximately 19.3 million new cancer cases and 10.0 million cancer deaths across the globe.The growing incidence of cancer is anticipated to drive the demand for oral clinical nutrition supplements. Moreover, oral clinical nutrition supplements play an important role in the management of Cancer-related malnutrition and in improving patient outcomes; hence, they are expected to propel the growth of the segment.
Oral Clinical Nutrition Supplement Market Product Form Insights
The Oral Clinical Nutrition Supplement Market segmentation by Product Form includes Liquid, Powder, and Ready-to-drink. The Liquid segment held the largest market share in 2023, and it is projected to continue its dominance throughout the forecast period. This is due to the ease of administration and high bioavailability of liquid supplements. The Ready-to-drink segment is expected to witness the highest CAGR during the forecast period, owing to the increasing demand for convenient and portable nutritional supplements. The Powder segment is anticipated to account for a significant market share due to its affordability and versatility.Key players in the Oral Clinical Nutrition Supplement Market include Nestle, Abbott, and Danone. The market is expected to witness significant growth in the coming years, driven by the rising prevalence of chronic diseases and the increasing demand for personalized nutrition.
Oral Clinical Nutrition Supplement Market Formula Composition Insights
The Oral Clinical Nutrition Supplement Market is segmented by formula composition into Standard formula, Disease-specific formula, and Modular formula. Among these, the Standard formula segment held the largest market share in 2023 and is expected to maintain its dominance throughout the forecast period. Standard formulas are designed to meet the general nutritional needs of patients who are unable to consume a regular diet. They are typically composed of a blend of macronutrients, micronutrients, and electrolytes. Disease-specific formulas are designed to meet the specific nutritional needs of patients with certain medical conditions, such as cancer, diabetes, or kidney disease.Modular formulas are designed to be customized to meet the individual nutritional needs of patients. They are typically composed of a base formula that can be supplemented with additional nutrients as needed. The increasing prevalence of chronic diseases is expected to drive the growth of the Oral Clinical Nutrition Supplement Market in the coming years.
Oral Clinical Nutrition Supplement Market Nutritional Content Insights
The Oral Clinical Nutrition Supplement Market is segmented based on nutritional content into high protein, high calorie, high fiber, and low sodium. High protein supplements are designed for individuals with increased protein needs, such as those recovering from surgery or illness. The market for high-protein oral clinical nutrition supplements is projected to reach USD 30.1 billion by 2024, growing at a CAGR of 7.2% from 2024 to 2032. High-calorie supplements are ideal for patients who need to gain weight or maintain a healthy weight.The market for high-calorie oral clinical nutrition supplements is expected to be valued at USD 22.3 billion by 2024, with a CAGR of 6.8% over the forecast period. High-fiber supplements support digestive health and regularity. The market for high-fiber oral clinical nutrition supplements is anticipated to grow at a CAGR of 6.5% from 2024 to 2032, reaching USD 15.2 billion by 2024. Low-sodium supplements are formulated for individuals with hypertension or other conditions that require sodium restriction. The market for low-sodium oral clinical nutrition supplements is projected to reach USD 12.4 billion by 2024, growing at a CAGR of 6.2% from 2024 to 2032.
Oral Clinical Nutrition Supplement Market Regional Insights
The regional segmentation of the Oral Clinical Nutrition Supplement Market provides valuable insights into the market's geographical distribution and growth potential. North America held the largest market share in 2023, driven by factors such as the presence of a large geriatric population, rising healthcare expenditure, and a growing awareness of the benefits of oral clinical nutrition supplements. The European market is also significant, with countries like Germany, France, and the United Kingdom contributing to its growth. The APAC region is expected to witness substantial growth in the coming years due to factors such as increasing healthcare spending, rising disposable income, and a growing awareness of malnutrition.South America and MEA are emerging markets with potential for growth as healthcare infrastructure and awareness about oral clinical nutrition supplements improve.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Oral Clinical Nutrition Supplement Market Key Players And Competitive Insights
Major players in the Oral Clinical Nutrition Supplement Market industry are focusing on expanding their product offerings and geographic reach. Leading Oral Clinical Nutrition Supplement Market players are investing heavily in research and development to introduce innovative products that meet the evolving needs of patients. The Oral Clinical Nutrition Supplement Market landscape is highly competitive, with several key players vying for market share. These players are adopting various strategies to gain a competitive edge, including mergers and acquisitions, partnerships, and new product launches. The competitive landscape of the Oral Clinical Nutrition Supplement Market is expected to remain fragmented in the coming years, with the entry of new players and the increasing adoption of Oral Clinical Nutrition Supplement by healthcare providers.Nestlé Health Science, a leading player in the Oral Clinical Nutrition Supplement Market, offers a wide range of products for patients with various nutritional needs. The company's portfolio includes products such as Boost, Resource, and Jevity, which are used to provide nutritional support to patients with conditions such as malnutrition, cancer, and digestive disorders. Nestlé Health Science has a strong presence and operates in over 100 countries. The company is committed to innovation and invests heavily in research and development to develop new products and technologies.Abbott Nutrition, another major player in the Oral Clinical Nutrition Supplement Market, offers a range of products for patients with nutritional deficiencies. The company's portfolio includes products such as Ensure, Glucerna, and Pediasure, which are used to provide nutritional support to patients with conditions such as diabetes, malnutrition, and digestive disorders. Abbott Nutrition has a presence and operates in over 150 countries. The company is committed to innovation and invests heavily in research and development to develop new products and technologies.
Key Companies in the Oral Clinical Nutrition Supplement Market Include
- Schreiber Foods
- Lactalis
- Mead Johnson Nutrition
- Arla Foods
- Dairy Farmers of America
- Danone
- Fonterra
- Nestle
- FrieslandCampina Ingredients
- Hochdorf Holding
- Agropur
- Royal FrieslandCampina
- Saputo
- Abbott
- Glanbia
Oral Clinical Nutrition Supplement Market Industry Developments
The Oral Clinical Nutrition Supplement market is projected to reach USD 130.0 billion by 2032, exhibiting a CAGR of 7.63% during the forecast period (2024-2032). The increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about the benefits of oral clinical nutrition supplements are key factors driving market growth. Recent news developments include the launch of new products by major players and collaborations between manufacturers and healthcare providers to improve patient outcomes. The market is expected to witness significant growth in emerging economies due to increasing healthcare investments and improving healthcare infrastructure.
Oral Clinical Nutrition Supplement Market Segmentation Insights
Oral Clinical Nutrition Supplement Market Patient Type Outlook
- Malnourished cancer patients
- Critically ill patients
- Trauma patients
- Elderly patients
Oral Clinical Nutrition Supplement Market Clinical Indication Outlook
- Cancer-related malnutrition
- Critical illness
- Trauma
- Sarcopenia
Oral Clinical Nutrition Supplement Market Product Form Outlook
- Liquid
- Powder
- Ready-to-drink
Oral Clinical Nutrition Supplement Market Formula Composition Outlook
- Standard formula
- Disease-specific formula
- Modular formula
Oral Clinical Nutrition Supplement Market Nutritional Content Outlook
- High protein
- High calorie
- High fiber
- Low sodium
Oral Clinical Nutrition Supplement Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
Oral Clinical Nutrition Supplement Market Report Scope
|
Report Attribute/Metric
|
Details
|
|
Market Size 2022
|
62.34(USD Billion)
|
|
Market Size 2023
|
67.1(USD Billion)
|
|
Market Size 2032
|
130.0(USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
7.63% (2024 - 2032)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2023
|
|
Market Forecast Period
|
2024 - 2032
|
|
Historical Data
|
2019 - 2023
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Schreiber Foods, Lactalis, Mead Johnson Nutrition, Arla Foods, Dairy Farmers of America, Danone, Fonterra, Nestle, FrieslandCampina Ingredients, Hochdorf Holding, Agropur, Royal FrieslandCampina, Saputo, Abbott, Glanbia.
|
|
Segments Covered
|
Patient Type, Clinical Indication, Product Form, Formula Composition, Nutritional Content, Regional.
|
|
Key Market Opportunities
|
Increasing geriatric population Rising demand for personalized nutrition Growing prevalence of chronic diseases Technological advancements in supplement formulations Expanding healthcare infrastructure
|
|
Key Market Dynamics
|
Rising prevalence of malnutrition Increasing demand for convenience Technological advancements Growing awareness of personalized nutrition Shift towards home healthcare.
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Frequently Asked Questions (FAQ) :
The oral clinical nutrition supplement market was valued at 67.1 billion U.S. dollars in 2023 and is projected to reach 130.0 billion U.S. dollars by 2032, exhibiting a CAGR of 7.63% during the forecast period.
North America is expected to dominate the oral clinical nutrition supplement market throughout the forecast period. In 2023, the region accounted for over 40% of the market revenue, and it is projected to maintain its dominance during the forecast period.
The increasing prevalence of chronic diseases, rising demand for personalized nutrition, and growing awareness about the benefits of oral clinical nutrition supplements are the primary factors driving the growth of the market.
Oral clinical nutrition supplements are primarily used for the nutritional support of patients with malnutrition or at risk of malnutrition. They are also used for the management of specific medical conditions, such as cancer, diabetes, and gastrointestinal disorders.
The key competitors in the oral clinical nutrition supplement market include Nestle, Abbott Laboratories, Danone, Fresenius Kabi, and Baxter International.
The major challenges faced by the market include intense competition, stringent regulatory requirements, and variations in reimbursement policies across different regions.
The growing demand for personalized nutrition, increasing awareness about the benefits of oral clinical nutrition supplements, and the expansion of the market into emerging economies present significant growth opportunities.
Some of the key trends shaping the market include the development of innovative products, the integration of digital technologies, and the growing focus on patient-centric care.
Oral clinical nutrition supplements are generally safe when used as directed by a healthcare professional. However, potential risks include gastrointestinal side effects, interactions with medications, and the risk of over-nutrition.
Oral clinical nutrition supplements are regulated as food products in most countries. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), establish guidelines for the safety and quality of these products.
